Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Feb 5;9(2):e87934.
doi: 10.1371/journal.pone.0087934. eCollection 2014.

Field efficacy of Vectobac GR as a mosquito larvicide for the control of anopheline and culicine mosquitoes in natural habitats in Benin, West Africa

Affiliations
Clinical Trial

Field efficacy of Vectobac GR as a mosquito larvicide for the control of anopheline and culicine mosquitoes in natural habitats in Benin, West Africa

Armel Djènontin et al. PLoS One. .

Abstract

Introduction: The efficacy of Vectobac GR (potency 200 ITU/mg), a new formulation of bacterial larvicide Bacillus thuringiensis var. israelensis Strain AM65-52, was evaluated against Anopheles gambiae and Culex quinquefasciatus in simulated field and natural habitats in Benin.

Methods: In simulated field conditions, Vectobac GR formulation was tested at 3 dosages (0.6, 0.9, 1.2 g granules/m² against An. gambiae and 1, 1.5, 2 g granules/m² against Cx. quinquefasciatus) according to manufacturer's product label recommendations. The dosage giving optimum efficacy under simulated field conditions were evaluated in the field. The efficacy of Vectobac GR in terms of emergence inhibition in simulated field conditions and of reduction of larval and pupal densities in rice fields and urban cesspits was measured following WHO guidelines for testing and evaluation of mosquito larvicides.

Results: Vectobac GR caused emergence inhibition of ≥80% until 21 [20]-[22] days for An. gambiae at 1.2 g/m² dose and 28 [27-29] days for Cx. quinquefasciatus at 2 g/m² in simulated field habitats. The efficacy of Vectobac GR in natural habitats was for 2 to 3 days against larvae and up to 10 days against pupae.

Conclusions: Treatment with Vectobac GR caused complete control of immature mosquito within 2-3 days but did not show prolonged residual action. Larviciding can be an option for malaria and filariasis vector control particularly in managing pyrethroid-resistance in African malaria vectors. Since use of larvicides among several African countries is being emphasized through Economic Community of West Africa States, their epidemiological impact should be carefully investigated.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Density reduction (DR) of An. gambiae old instars larvae estimated by the regression model according to the number of days after treatment.
Figure 2
Figure 2. Density reduction (DR) of Cx. quinquefasciatus young instars larvae estimated by the regression model according to the number of days after treatment.
Figure 3
Figure 3. Density reduction (DR) of Cx. quinquefasciatus old instars larvae estimated by the regression model according to the number of days after treatment.
Figure 4
Figure 4. Density reduction (DR) of Cx. quinquefasciatus pupae estimated by the regression model according to the number of days after treatment.

References

    1. WHO (2012) World Malaria Report.
    1. WHO (2013) Sustaining the drive to overcome the global impact of neglected tropical diseases. Second WHO report on neglected tropical diseases. WHO/HTM/NTD/2013.1. Geneva, World Health Organization.
    1. Townson H, Nathan MB, Zaim M, Guillet P, Manga L, et al. (2005) Exploiting the potential of vector control for disease prevention. Bull World Health Organ 83: 942–947. - PMC - PubMed
    1. Matthew TB, Godfray HCJ, Read AF, Berg Hvd, Tabashnik BE, et al. (2012) Lessons from Agriculture for the Sustainable Management of Malaria Vectors. PLoS Med 9. - PMC - PubMed
    1. WHO (2008) WHO position statement on integrated vector management. Weekly epidemiological record 20: 177–184. - PubMed

Publication types

LinkOut - more resources